Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ANAPC5 antibody (AA 1-250)

ANAPC5 Reactivity: Human WB, IHC, IP Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN6136867
  • Target See all ANAPC5 Antibodies
    ANAPC5 (Anaphase Promoting Complex Subunit 5 (ANAPC5))
    Binding Specificity
    • 15
    • 9
    • 5
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-250
    Reactivity
    • 53
    • 15
    • 6
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Human
    Host
    • 52
    • 1
    Rabbit
    Clonality
    • 53
    Polyclonal
    Conjugate
    • 21
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This ANAPC5 antibody is un-conjugated
    Application
    • 42
    • 20
    • 13
    • 13
    • 8
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP)
    Sequence
    MASVHESLYF NPMMTNGVVH ANVFGIKDWV TPYKIAVLVL LNEMSRTGEG AVSLMERRRL NQLLLPLLQG PDITLSKLYK LIEESCPQLA NSVQIRIKLM AEGELKDMEQ FFDDLSDSFS GTEPEVHKTS VVGLFLRHMI LAYSKLSFSQ VFKLYTALQQ YFQNGEKKTV EDADMELTSR DEGERKMEKE ELDVSVREEE VSCSGPLSQK QAEFFLSQQA SLLKNDETKA LTPASLQKEL NNLLKFNPDF
    Cross-Reactivity
    Human, Mouse, Rat
    Characteristics
    Polyclonal Antibodies
    Purification
    Affinity purification
    Immunogen
    Recombinant fusion protein containing a sequence corresponding to amino acids 1-250 of human ANAPC5 (NP_057321.2).
    Isotype
    IgG
    Top Product
    Discover our top product ANAPC5 Primary Antibody
  • Application Notes
    WB,1:500 - 1:2000,IHC,1:50 - 1:200,IP,1:50 - 1:100
    Comment

    HIGH QUALITY

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    ANAPC5 (Anaphase Promoting Complex Subunit 5 (ANAPC5))
    Alternative Name
    ANAPC5 (ANAPC5 Products)
    Synonyms
    APC5 antibody, DDBDRAFT_0206386 antibody, DDBDRAFT_0234269 antibody, DDB_0206386 antibody, DDB_0234269 antibody, zgc:55800 antibody, wu:fb75a09 antibody, ANAPC5 antibody, MGC89697 antibody, 2510006G12Rik antibody, AA408751 antibody, AA536819 antibody, AA986414 antibody, Anpc5 antibody, F12K11.7 antibody, F12K11_7 antibody, anaphase promoting complex subunit 5 antibody, anaphase-promoting complex subunit 5 antibody, anaphase promoting complex subunit 5 L homeolog antibody, anaphase-promoting complex subunit antibody, anaphase-promoting complex subunit Apc5 antibody, ANAPC5 antibody, anapc5 antibody, LOC100093215 antibody, anapc5.L antibody, Anapc5 antibody, AT1G06590 antibody, apc5 antibody
    Background
    This gene encodes a tetratricopeptide repeat-containing component of the anaphase promoting complex/cyclosome (APC/C), a large E3 ubiquitin ligase that controls cell cycle progression by targeting a number of cell cycle regulators such as B-type cyclins for 26S proteasome-mediated degradation through ubiquitination. The encoded protein is required for the proper ubiquitination function of APC/C and for the interaction of APC/C with transcription coactivators. It also interacts with polyA binding protein and represses internal ribosome entry site-mediated translation. Multiple transcript variants encoding different isoforms have been found for this gene. These differences cause translation initiation at a downstream AUG and result in a shorter protein (isoform b), compared to isoform a.,ANAPC5,APC5,Cell Biology & Developmental Biology,Cell Cycle,Ubiquitin,Ubiquitin-Proteasome Signaling Pathway,ANAPC5
    Molecular Weight
    25 kDa/72 kDa/85 kDa
    Gene ID
    51433
    UniProt
    Q9UJX4
    Pathways
    M Phase
You are here:
Support